Lampertico, P <br/><br/>
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Dec 1997 
 - 1621-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0270-9139 
<br/><br/><label>Standard No.: </label>10.1002/hep.510260634  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alanine Transaminase--blood<br/>Biopsy<br/>DNA, Viral--blood<br/>Female<br/>Follow-Up Studies<br/>Hepatitis B Antibodies--analysis<br/>Hepatitis B Surface Antigens--blood<br/>Hepatitis B e Antigens--blood<br/>Hepatitis B virus--genetics<br/>Hepatitis B, Chronic--blood<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--adverse effects<br/>Liver--pathology<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Recombinant Proteins